Home532523 • BOM
add
Biocon Ltd
Previous close
₹323.15
Day range
₹322.45 - ₹332.30
Year range
₹231.35 - ₹395.65
Market cap
396.60B INR
Avg Volume
170.80K
P/E ratio
27.55
Dividend yield
0.15%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 35.90B | 3.70% |
Operating expense | 21.42B | 8.03% |
Net income | -160.00M | -112.74% |
Net profit margin | -0.45 | -112.40% |
Earnings per share | -0.19 | -115.53% |
EBITDA | 6.78B | -6.58% |
Effective tax rate | 72.46% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 26.50B | -30.00% |
Total assets | 571.28B | 4.67% |
Total liabilities | 304.08B | 0.36% |
Total equity | 267.20B | — |
Shares outstanding | 1.23B | — |
Price to book | 1.89 | — |
Return on assets | — | — |
Return on capital | 1.56% | — |
Cash Flow
Net change in cash
(INR) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -160.00M | -112.74% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets.
Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA.
Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Founded
1978
Headquarters
Website
Employees
16,315